A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.
NCT06839131 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 94
Last updated 2026-05-05
Summary
The purpose of the study is to evaluate the safety of SPH9788 tablets in healthy subjects.
Conditions
- Healthy Participants
Interventions
- DRUG
-
SPH9788
SPH9788 tablets administered orally
- DRUG
-
Matching placebo administered orally
Sponsors & Collaborators
-
Shanghai Pharmaceuticals Holding Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-02
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects
NCT04880512 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety, Tolerability and PK/PD of SHR1459 in Healthy Volunteers
NCT03668509 ·Status: UNKNOWN ·Phase: PHASE1
-
A Single and Multiple-Dose Study of SB1578
NCT01235871 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics Profile and Tolerance of HRS-9231 in Healthy Subjects
NCT07123376 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Bioavailability of SHR0302 in Healthy Subjects
NCT04712838 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects
NCT06022354 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple s.c Doses HS-20004 in Healthy Chinese Volunteers
NCT02746315 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Participants
NCT07345364 ·Status: RECRUITING ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers
NCT04652297 ·Status: UNKNOWN ·Phase: PHASE1
-
The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.
NCT06994286 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple Administration
NCT07232758 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ 53718678 in Healthy Japanese Adult Participants
NCT02398591 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects
NCT06214858 ·Status: RECRUITING ·Phase: PHASE1
-
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2061
NCT07241910 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants.
NCT03530917 ·Status: COMPLETED ·Phase: PHASE1
-
A PHASE I, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE DOSE ESCALATION STUDY TO INVESTIGATE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SHR0534 IN HEALTHY VOLUNTEERS
NCT02749097 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of SGB-9768 in Adult Healthy Volunteers
NCT06501573 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Phase I Study of SHR -2001 in Healthy Subjects
NCT05942612 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study of MK-6194 in Healthy Chinese Participants (MK-6194-014)
NCT06821334 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of SHR-2173 in Healthy Subjects
NCT06995001 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Dose Study of 9MW3011 in Chinese Healthy Subject
NCT06389942 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD)
NCT05058118 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants
NCT06368440 ·Status: COMPLETED ·Phase: PHASE1
-
SB17170 Phase1 Trial in Healthy Volunteer
NCT05795192 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults
NCT03597217 ·Status: COMPLETED ·Phase: PHASE1